** Shares of Carmat ALCAR.PA are up 10% after the French
artificial heart maker said it had reached the 100 implant
milestone for its Aeson Total Artificial Heart
** Carmat also confirms expectations for it to double its
sales in 2025
** "This milestone, though symbolic, is encouraging for
Carmat sales," Portzamparc analyst Mohamed Kaabouni says
** Carmat needs 500 implants a year to achieve
profitability, Kaabouni adds, noting this number was 42 in 2024
** If the gains hold, Carmat's shares will see their best
day since October 9
(Reporting by Gianluca Lo Nostro)
((gianluca.lonostro@thomsonreuters.com;))